Transthyretin Predicts Cardiovascular Outcome In Hemodialysis Patients With Diabetes Mellitus Type 2
BMI and albumin are commonly accepted parameters to recognize wasting in dialysis patients and are powerful predictors of morbidity and mortality. However, both parameters reveal limitations and may not cover the entire range of patients with wasting. The visceral protein transthyretin (TTR) may be...
Main Authors: | Andrea Henze, Katharina Espe, Christoph Wanner, Vera Krane, Jens Raila, Berthold Hocher, Florian J. Schweigert, Christiane Drechsler |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2012-06-01
|
Series: | Kidney Research and Clinical Practice |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211913212004330 |
Similar Items
-
Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay
by: Raila Jens, et al.
Published: (2004-09-01) -
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients
by: Mustea Alexander, et al.
Published: (2005-10-01) -
Alteration of Transthyretin Microheterogeneity in Serum of Multiple Trauma Patients
by: Florian J. Schweigert, et al.
Published: (2007-01-01) -
Serum transthyretin in hemodialysis patients : relationship to nutritional status
by: Duggan, Annmarie
Published: (1997) -
Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases
by: Elżbieta Wieczorek, et al.
Published: (2021-07-01)